Aprazer Healthcare Launched MEROAXIS

Posted by

Aprazer

On December 19, 2020

Comments Off

Launch Date: 19/12/20

Aprazer Healthcare Launched MEROAXIS (Meropenem Inj) which is a medication indicated for the treatment of susceptible infections including intra-abdominal infections, meningitis, respiratory tract infections (Including cystic fibrosis patients) septicemia, skin infections, urinary tract infections and infections in immune-compromised patients.

Newer Aprazer Healthcare Launched XGRAF

Older Aprazer Healthcare Launched HQKAST

Disclaimer : This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/ purchase any medicine.